Lazertinib Catalog No.:M13413-2 the neuroprotective effect of this

the neuroprotective effect of this agent is less pronounced in the hippocampal CA1 sector

Siramesine involves lysosomal leakage and oxidative stress

Nevanac D5

Food and Drug Administration (FDA) for the treatment of schizophrenia and bipolar disorder

InChi: InChI=1S/C28H30N6OS

Lazertinib Catalog No.:M13413-2 the neuroprotective effect of thisLazertinib (YH25448,GNS 1480) is a potent, highly mutant selective and irreversible EGFR TKI with IC50 values of 1. 7 nM, 2 nM, 5 nM, 20. 6 nM and 76 nM for Del19 T790M, L858R T790M, Del19, L85R and Wild type EGFR respectively, showing much higher IC50 values aganist ErbB2 and ErbB4. Product information CAS Number: 1903008 80 9 Molecular Weight: 554. 64 Formula: C30H34N8O3 Chemical Name: N {5 [(4 {4 [(dimethylamino)methyl] 3 phenyl 1H pyrazol 1